Drug of Abuse (DOA) Testing Market – Analysis and Forecast To 2024 | Siemens AG, Merck KGaA, Waters Corporation.

Drug of Abuse (DOA) testing is the clinical detection of one or more drugs within the human system, by sample testing. This is done to provide clinical intervention or for monitoring of illegal drug intake. Global DOA testing market was poised at USD 4,938.6 million in 2017. The testing for DOA requires products such as immunoassay analyzers, chromatography instruments, breath analyzers, rapid test kits, and assay kits & reagents. The rapid test kits are driving the growth of the DOA testing market and are estimated to hold the largest share in 2017.

Download Free Report Sample At: https://www.vynzresearch.com/healthcare/drug-of-abuse-doa-testing-market/request-sample

The number of suppliers in the DOA testing market is high, however the products utilized in DOA testing needs to follow stringent government regulations, the threat of forward integration is low leading to a moderate bargaining power of suppliers in the market.

Geographically, North America accounts for the largest share in the DOA testing market, globally. This contribution is due to the adaptation of technologically advanced products for DOA testing, increased demand for illicit drugs in the region, large scale drug trafficking, and the increasing government initiative to spread awareness against DOA. Moreover, the DOA testing industry is expected to be witness the fastest growth in Asia-Pacific. 

The major player in the global DOA testing market includes Danaher Corporation, Siemens AG, Merck KGaA, Drägerwerk AG & Co. KGaA, bioMérieux S.A., Waters Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics Inc., Laboratory Corporation of America Holdings,  Abbott Laboratories, ThermoFisher Scientific Inc., Express Diagnostics Int'l, Inc., Randox Laboratories Ltd., Psychemedics Corporation, and Bio-Rad Laboratories, Inc.

Read More: https://www.vynzresearch.com/healthcare/drug-of-abuse-doa-testing-market

The leading players through acquisitions are attaining competency and larger market share in the global DOA testing industry. For example, in January 2018, ACM Global Laboratories, an affiliate of Rochester Regional Health announced the strategic acquisition of DrugScan, Inc. and DSI Medical Services, Inc. The acquisition was made to establish a laboratory service portfolio and drug testing capabilities.

About VynZ Research

VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Contact

Manager: Client Care

Toll-Free: 18882533960

Email: kundan@vynzresearch.com

Website: www.vynzresearch.com